Table 2.
Demographic and baseline variables for patients included
| All (77) | SRFI neg. (34) | SRFI pos. (43) | P value | |
| Age, yr (median range) | 43 (18-73) | 46 (19-73) | 43 (18-73) | NS1 |
| Female/male ratio (%) | 61/16 | 25/9 | 36/7 | NS2 |
| Abdominal pain/discomfort (mm) | 53(3-89) | 58 (3 89) | 50 (16-76) | NS1 |
| Bloating (mm) | 55 (20-84) | 58 (22-83) | 54 (20-84) | NS1 |
| Stool frequency [median (range)] | 1.5 (0-4) | 1.6 (1-4) | 1.5 (0-4) | NS3 |
| Boston scale stool consistency | 4.4 (1.9-6.0) | 4.6 (1.9-6.0) | 4.3 (2.6-5.9) | NS1 |
1
Independent samples t-test;
2
The χ2 test;
3
Mann-Whitney U. IBS: Measures are mean preregistration values (95%CI) unless otherwise stated. Treatment group differences were tested. SRFI: Self reported fructose intolerance; NS: Not significant.